November 12, 2025 · Form 4 insider transaction
Telman Deborah H sold 17,181 shares of Gilead Sciences, Inc. at $124.00 per share, a transaction worth $2.13M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.